Columbus Circle Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-422,825
Closed -$36.5M 176
2018
Q3
$36.5M Sell
422,825
-19,663
-4% -$1.4M 0.73% 48
2018
Q2
$25.7M Buy
442,488
+39,503
+10% +$1.93M 0.53% 78
2018
Q1
$16.2M Sell
402,985
-441,575
-52% -$16.7M 0.33% 105
2017
Q4
$29.4M Buy
844,560
+101,233
+14% +$3.36M 0.56% 62
2017
Q3
$24.6M Buy
743,327
+319,578
+75% +$10.5M 0.42% 81
2017
Q2
$14.7M Buy
+423,749
New +$12.3M 0.24% 101

Other funds holding TDOC

Columbus Circle Investors's TDOC Position: Q4 2018 in Review

Columbus Circle Investors sold out of Teladoc Health (TDOC) in Q4 2018, closing a stake of 422,825 shares — an estimated $36.5M sold.

Columbus Circle Investors first reported a position in TDOC in Q2 2017 and held it in 6 quarters. The position peaked at $36.5M in Q3 2018. 326 funds tracked by Wall St. Rank hold TDOC as of Q4 2018.

  • Columbus Circle Investors reported no remaining Teladoc Health position as of Q4 2018 after selling out during the quarter.
  • Columbus Circle Investors sold 422,825 Teladoc Health shares in Q4 2018, an estimated $36.5M.
  • Columbus Circle Investors first reported a position in Teladoc Health in Q2 2017 and held it in 6 quarters.
  • Columbus Circle Investors's Teladoc Health position peaked at $36.5M in Q3 2018.
  • 326 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2018.

Based on Columbus Circle Investors's 13F filing for Q4 2018, filed 6 Feb 2019.